Liberum hikes price target on 4imprint.


Analysts at Liberum raised their target price on direct marketing business 4imprint Group from 3,000.0p to 3,300.0p on Monday, stating recent strong momentum for the company looked set to continue.

  • 4Imprint Group
  • 19 April 2024 17:21:49

Source: Sharecast

Liberum said there has been "good momentum" at 4imprint, with July 2021 orders at 112% of those seen in July 2019 amid what appears to be "an element of pent-up demand".

The analysts also increased their full-year 2021 earnings per share estimates by 6% on the back of 4imprint's recent results, despite maintaining "a cautious view" on margin progress and higher tax.

"There are still a number of uncertainties, but we believe recovered EPS in the range of 134c (97p) to 211c (152p) is achievable in FY 23. The middle of the range of 173c would represent 32% upside to our current estimate," said Liberum, which also reiterated their 'buy' rating on the stock.

"We expect a much stronger recovery from Covid than the GFC. At the results, we reduced our FY 21 net cash (excluding leases) estimate of $55m to $50m due to the interim dividend, but we expect management to continue to maintain a cash buffer."


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: -59.37 ( -0.31 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

Whether you're looking for a Share Dealing Account, Stocks and Shares ISA or a Self-Invested Personal Pension (SIPP), we've got an account to suit your needs..

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.